AltPep
David Goel joined the Board of Directors in December 2020. David is Co-founder and sole Managing General Partner of Matrix Capital Management Company, LP, an investment fund focused on technology and life sciences. David serves as a director on several private company boards and previously served as a director of Popular, Inc., a public financial services company. He is a member of the Board of Trustees of The Winsor School and the Museum of Fine Arts in Boston, Massachusetts. David holds a BA, magna cum laude, from Harvard University.
This person is not in the org chart
This person is not in any offices
AltPep
AltPep Corporation is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases. They are currently focusing on CNS disorders, in particular Alzheimer’s Disease (AD). They target and seek to neutralize the early toxic oligomers behind these amyloid diseases, which in the case of AD are due to aggregation of the Amyloid-beta peptide (Abeta).